Results based on clinical trial averages
Novo Nordisk's Saxenda injectable drug is aimed at the obesity market The daily injectable drug has been priced at $1,000 a month, far higher than its rival oral treatments, Vivus' Qsymia, Arena/Eisai's Belviq and Contrave/Takeda's Orexigen
Reversible glutathiolation of caspase-3 by glutaredoxin as a novel redox signaling mechanism in tumor necrosis factor-alpha-induced cell death
Microscopically, differentiated (simplex) PeIN is characterized by a thickened epithelium, usually associated with elongated and anastomosing rete ridges, subtle abnormal maturation (enlarged keratinocytes with abundant eosinophilic cytoplasm), whorling and keratin pearl formation (usually in deep rete ridges), prominent intercellular bridges (spongiosis and sometimes acantholysis), and atypical basal cells with hyperchromatic nuclei (116)
External Heres the simplest way to understand it: They are solving different problems
This podcast has become a powerful space where people living with obesity, GLP-1 medication users, clinicians, and advocates share their stories, expertise, and lived experience
